Skip to main content
. 2020 Nov 26;14:4079–4088. doi: 10.2147/OPTH.S288224

Table 6.

Long-Term Visual Outcomes

Long-Term Visual Outcomes MOG-IgG + ON AQP4-IgG + ON p-value
Final VA
● Final VA, median (range), logMAR 0.0 (0–0.48) 0.4 (0–2.9) < 0.001*
● Final VA worse than or equal to 1.0 logMAR, n of eyes/n of eyes with available data (%) 0/28 (0.0) 19/55 (34.6) < 0.001*
ON relapse, n of patients (%) 7 (43.8) 25 (58.1) 0.32
ON ARR, median (range) 0.56 (0.11–2.50) 0.35 (0.13–1.40) 0.20
Time from ON onset to first ON relapse, median (range), months 7 (5–38) 17 (3–90) 0.25

Note: *Statistically significant (p < 0.05).

Abbreviations: ON, optic neuritis; MOG-IgG +, myelin oligodendrocyte glycoprotein autoantibody-positive; AQP4-IgG +, aquaporin-4 autoantibody-positive; VA, visual acuity; logMAR, logarithm of the minimum angle of resolution; n, number; ARR, annualized relapse rate.